The drugmaker said it is confident its painkiller does not have the heart health issues brought forward in the recall of Merck's Vioxx because routine monitoring of three long-term studies has not shown any cardiovascular risk. Ongoing trials contain information on more than 6,000 people taking Celebrex, a placebo or pain relief medicine naproxen.

Related Summaries